Free Trial

Haleon (HLN) Stock Price, News & Analysis

$8.49
+0.02 (+0.24%)
(As of 07/8/2024 ET)
Today's Range
$8.49
$8.57
50-Day Range
$8.19
$8.64
52-Week Range
$7.70
$8.96
Volume
2.58 million shs
Average Volume
3.11 million shs
Market Capitalization
$38.77 billion
P/E Ratio
28.30
Dividend Yield
2.47%
Price Target
N/A

Haleon MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.40% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.50mentions of Haleon in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.87%
From $0.46 to $0.51 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.18 out of 5 stars

Medical Sector

286th out of 876 stocks

Toilet Preparations Industry

7th out of 13 stocks

HLN stock logo

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

HLN Stock News Headlines

Next hot AI projects are NOT on the Nasdaq
Nearly 9 out of 10 Americans totally ignore this market. And you’ll probably never hear your broker mention it.
Next hot AI projects are NOT on the Nasdaq
Nearly 9 out of 10 Americans totally ignore this market. And you’ll probably never hear your broker mention it.
Sales Call
Haleon shares slide as revenue declines
Stocks Making Big Moves Today
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/16 Dividend
3/14/2024
Last Earnings
5/01/2024
Dividend Payable
5/16/2024
Today
7/08/2024
Next Earnings (Estimated)
8/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
25,408
Year Founded
N/A

Profitability

Net Income
$1.30 billion
Pretax Margin
14.40%

Debt

Sales & Book Value

Annual Sales
$14.05 billion
Cash Flow
$0.37 per share
Book Value
$4.51 per share

Miscellaneous

Outstanding Shares
4,566,150,000
Free Float
N/A
Market Cap
$38.77 billion
Optionable
Not Optionable
Beta
0.24
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Brian James McNamara (Age 58)
    CEO & Executive Director
    Comp: $4.32M
  • Mr. Tobias Hannes Hestler (Age 52)
    CFO & Executive Director
    Comp: $2.4M
  • Ms. Sonya Ghobrial (Age 50)
    Head of Investor Relations
  • Ms. Tamara Rogers (Age 54)
    Chief Marketing Officer
  • Mr. Filippo Lanzi
    President of EMEA & LatAm
  • Mr. Keith Choy (Age 55)
    President of Asia Pacific
  • Ms. Lisa Paley (Age 57)
    President of North America
  • Mr. Franck Riot (Age 56)
    Chief R&D Officer
  • Mr. Bjorn Timelin
    Head of Strategy
  • Ms. Namrata P. Patel (Age 58)
    Chief Supply Chain Officer

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc reported earnings per share (EPS) of $0.12 for the last quarter, exceeding analysts' estimates by $0.01. This indicates strong financial performance.
  • Analysts have given Haleon plc a consensus rating of "Moderate Buy," suggesting positive sentiment and growth potential in the stock.
  • Recent institutional investments in Haleon plc, such as Procyon Advisors LLC increasing its stake by 559.9%, indicate confidence in the company's future prospects.
  • Positive analyst coverage from reputable firms like HSBC and Berenberg Bank, both issuing "buy" ratings for the stock, further supports the investment case for Haleon plc.
  • Despite trading down slightly, Haleon plc's stock price remains stable around $8.43, presenting a potentially attractive entry point for investors.

Cons

Investors should be bearish about investing in Haleon plc for these reasons:

  • While the company's EPS performance was positive, the revenue of $3.70 billion for the last quarter was slightly below analyst estimates, indicating potential challenges in revenue growth.
  • There is a debt-to-equity ratio of 0.53 for Haleon plc, which may raise concerns about the company's leverage and financial stability.
  • Market trading data shows a slight decline in Haleon plc's stock price, which could be a red flag for short-term investors looking for immediate gains.
  • The company's quick ratio of 0.73 and current ratio of 1.04 may suggest liquidity challenges or difficulties in meeting short-term obligations.
  • While analysts have given positive ratings, the stock has only one "hold" rating, indicating some uncertainty or mixed opinions among analysts regarding the future performance of Haleon plc.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 2, 2024. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

HLN Stock Analysis - Frequently Asked Questions

How have HLN shares performed this year?

Haleon's stock was trading at $8.23 at the start of the year. Since then, HLN stock has increased by 3.2% and is now trading at $8.49.
View the best growth stocks for 2024 here
.

How were Haleon's earnings last quarter?

Haleon plc (NYSE:HLN) released its quarterly earnings data on Wednesday, May, 1st. The company reported $0.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.01. The business had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.71 billion. Haleon had a trailing twelve-month return on equity of 13.17% and a net margin of 9.68%.

Who are Haleon's major shareholders?

Haleon's top institutional shareholders include Douglas Lane & Associates LLC (0.19%), First Hawaiian Bank (0.01%), Confluence Investment Management LLC and Marcum Wealth LLC.

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 7/9/2024 by MarketBeat.com Staff

From Our Partners